GO
Loading...

Merck & Co Inc

More

  • Pfizer Profit Slips, Hurt by Generic Drugs Thursday, 17 Apr 2008 | 9:40 AM ET

    Pfizer on Thursday reported a worse-than-expected decline in first-quarter earnings after declining sales of cholesterol fighter Lipitor and medicines now facing generic competition, sending shares down almost 4 percent.

  • Stocks Rally to the End; Intel Powers Techs Wednesday, 16 Apr 2008 | 4:53 PM ET

    Stocks finished at their highs for the day Wednesday as investors cheered the latest round of earnings, which included Intel and JPMorgan.

  • Stocks Rebound After 'Beige' Mood Swing Wednesday, 16 Apr 2008 | 3:08 PM ET

    Stocks rose sharply Wednesday as investors cheered the latest round of earnings, which included Intel and JPMorgan Chase.

  • Merck Misrepresented Vioxx Data: JAMA Report Tuesday, 15 Apr 2008 | 3:47 PM ET

    A new report in the Journal of the American Medical Association is highly critical of drugmaker Merck and its handling of the painkiller Vioxx.

  • AstraZeneca Shares Leap on Nexium Settlement Deal Tuesday, 15 Apr 2008 | 5:50 AM ET

    AstraZeneca has settled U.S. patent litigation against India's Ranbaxy Laboratories over its top-selling drug, ulcer pill Nexium, securing future sales and sending its shares soaring.

  • Lightning Round: Motorola, Pfizer, Boeing and More Friday, 11 Apr 2008 | 6:31 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Lightning Round: Yahoo, Petrobras, Ambac and More Thursday, 10 Apr 2008 | 6:35 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • CBOE Volatility Close to Low for the Year Thursday, 10 Apr 2008 | 12:37 PM ET

    With good news from Walmart and Goldman CEO Blankfein saying we are closer to the end of the current financial crisis than the beginning, the markets are rallying. Is Blankfein right or is it the calm before the storm?

  • MannKind Being Its Own "Man" About Inhalable Insulin Thursday, 10 Apr 2008 | 12:22 PM ET

    This morning there's a plethora of stuff to blog about: the Takeda-Millennium deal, more commentary about Merck and Schering-Plough and the extent of the Vytorin/Zetia fallout, Genentech's biotech bellweather earnings after the closing bell today, just to name a few.

  • Merck: Cramer's No. 1 Dow Stock Wednesday, 9 Apr 2008 | 7:08 PM ET

    He's expecting a full recovery – and more – for this company.

  • CNBC and other media outlets have done a significant amount of reporting on cardiologists' reaction to the Vytorin/Zetia study and the effect the ACC panel's opinion might have on the heart doctors' prescription writing.

  • Stocks End Lower On WaMu, Fed Minutes Tuesday, 8 Apr 2008 | 3:08 PM ET

    Stocks closed lower amid more bad news in the financial sector and a report showing the Federal Reserve is more worried about a recession than it has previously indicated.

  • Your First Move For Monday Apr. 7th Friday, 4 Apr 2008 | 7:09 PM ET

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!

  • My Merck/Schering-Plough Coverage Draws Your Emails Friday, 4 Apr 2008 | 5:02 PM ET

    This week started out with Merck shares suffering their worst loss since the day the drugmaker recalled Vioxx and Schering-Plough shares posting their worst one-day decline ever. But yesterday, SGP had its biggest percentage gain in eight years and today it's finishing the week as the sector's biggest percentage gainer.

  • Merrill News Helps Keep Stocks Afloat Thursday, 3 Apr 2008 | 4:51 PM ET

    Stocks logged another lackluster session Thursday in the wake of Tuesday's spectacular rally as the market digested a mixed bag of economic data and a congressional hearing on the Bear Stearns bailout.

  • Rally Fizzles as Oil Creeps Up Near $105 Wednesday, 2 Apr 2008 | 5:02 PM ET

    Stocks finished slight lower Wednesday as the financial-driven rally that kicked off the quarter Tuesday lost steam. Energy, retail and chips finished mostly higher.

  • Vytorin Battle Pits Merck/Schering-Plough Vs Pfizer Tuesday, 1 Apr 2008 | 11:03 AM ET

    Given investor reaction to the Vytorin/Zetia news yesterday, you might draw the conclusion the huge cholesterol drug franchise might be doomed. Sure, analysts say, prescriptions and sales are gonna go down some more, but they're not going to zero.

  • Schering CEO Speaks on Vytorin Monday, 31 Mar 2008 | 6:59 PM ET

    "We stand behind our product," Fred Hassan says. But does Cramer?

  • Stocks Gain On Last Day Of Worst Quarter In 5 Years Monday, 31 Mar 2008 | 6:29 PM ET

    Investors bid the Dow higher as the price of oil and other commodities declined. The rally caps a negative quarter for all the major averages. What's the "Word on the Street?"

  • Stocks End on High Note But Quarter Is Sour Monday, 31 Mar 2008 | 5:17 PM ET

    Stocks advanced Monday, led by financials, as the market looked for insight into the second quarter and braced for closing its worst quarter in 5 1/2 years.